Thelansis

 Hairy cell leukemia (HCL) is a rare, slow-growing type of leukemia that begins in the B cell (B lymphocyte). B cells are white blood cells that aid the body in fighting infection and are an essential component of the immune system. It is a clonal disorder with the presence of the V600E BRAF mutation in most cases. Patients frequently complain of non-specific symptoms such as fatigue, weakness, and cytopenia symptoms. This activity examines the diagnosis and treatment of hairy cell leukemia, as well as the role of the interprofessional team in improving care for patients with this condition. The morphological evidence of hairy cells under microscopic examination is used to diagnose HCL. Patients with this condition frequently experience non-specific symptoms such as fatigue and weakness and symptoms associated with cytopenias and splenomegaly. On presentation, eighty percent of patients will have significant cytopenias, with less than ten percent having severe pancytopenia. While s...

  Hairy cell leukemia (HCL) is a rare, slow-growing type of leukemia that begins in the B cell (B lymphocyte). B cells are white blood cells that aid the body in fighting infection and are an essential component of the immune system. It is a clonal disorder with the presence of the V600E BRAF mutation in most cases. Patients frequently complain of non-specific symptoms such as fatigue, weakness, and cytopenia symptoms. This activity examines the diagnosis and treatment of hairy cell leukemia, as well as the role of the interprofessional team in improving care for patients with this condition. The morphological evidence of hairy cells under microscopic examination is used to diagnose HCL. Patients with this condition frequently experience non-specific symptoms such as fatigue and weakness and symptoms associated with cytopenias and splenomegaly. On presentation, eighty percent of patients will have significant cytopenias, with less than ten percent having severe pancytopenia. While ...